Aurenar

Seed
aurenar.com Biotech & Healthcare Saint Louis, United States
Total Funding $5.7M
Latest Round $5.7M Seed
Last Announced Jul 28, 2026
Investors Undisclosed
Decision Makers Profile Active

About Aurenar

Aurenar develops non-invasive neuromodulation devices to modulate inflammation and support intensive care patients.

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Seed
Global Headquarters Saint Louis, United States
Tracked Since Sep 29, 2026

Web & Domain Identity

Official Website aurenar.com
Domain Registered Date Jan 30, 2023

Social & Network Presence

X / Twitter Profile Not linked
LinkedIn Corporate Not linked

Company Milestones & Timeline

2 Events
  1. Capital Raise

    Raised $5,700,000 · Seed

    fundraisingfox.com

  2. Milestone

    Website domain registered

    aurenar.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Aurenar.

Funding History

1 Round
Seed · Jul 28, 2026
$5,700,000

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

START FREE WITH 50 CREDITS
Recently funded startups
New SaaS launches
Never pay twice for contacts